How Filler Can Block Blood Flow: The Science Explained

A 2022 scientific review in the journal Molecules pulled together laboratory, animal and human research on what actually happens when hyaluronic acid filler blocks a blood vessel. Its main message for patients is that this rare complication involves more than a simple plug, and that speed of treatment is the single most important factor in a good outcome.

Why this was studied

Vascular occlusion, when filler interrupts blood flow through an artery or vein, is uncommon, but it is the most serious risk of filler treatment. It can damage skin and, very rarely, affect vision. Doctors have long known what it looks like and how to respond, but the detailed biology behind it has been less clear. Understanding that biology helps explain why certain treatments work and points toward better ones. For the clinical side, see our article on vascular occlusion and why filler belongs in a medical setting.

What the review covered

The author, a physician, reviewed published studies on how filler gets into blood vessels, what happens once it is there, and how the body reacts. Much of the detailed evidence comes from experiments in rats, rabbits and mice, along with laboratory tests and smaller human reports.

The science in plain language

Inside the vessel, not just pressing on it

There are two ways filler might cut off blood flow: by being injected into a vessel, or by pressing on a vessel from outside. The review concludes that injection into the vessel is most likely the common cause. Pressure from outside is possible but appears rare, mainly in areas with a very limited blood supply.

The author describes the process as a series of steps: the needle tip enters a vessel, filler is pushed in under pressure, fragments of gel travel downstream, and they lodge in smaller vessels. Depending on how much filler enters and where, the blockage may be scattered in tiny branches or form a larger plug.

Clotting and inflammation add to the problem

Animal research suggests that the gel does not just sit there. It appears to activate platelets, the blood cells involved in clotting, quickly forming a clot around the filler. Laboratory tests in which filler mixed with platelet-free blood did not clot support the idea that platelets play a central role. Inflammation and damage to the vessel lining follow.

Injury when blood flow returns

When blood flow is restored, the returning oxygen can briefly cause more harm through unstable molecules that injure tissue. This is called reperfusion injury, and it is one reason why some damage may appear even after treatment.

What it means for treatment

The review discusses how these findings relate to care:

• Time matters most. Research suggests the benefit of treatment drops sharply after the first few hours, which is why clinics keep emergency protocols and supplies ready.
• Hyaluronidase is the main treatment. This enzyme breaks down hyaluronic acid. The review notes that it is active in the bloodstream for only a few minutes, which helps explain why repeated doses are often needed. Our article on dissolving filler with hyaluronidase explains the enzyme further.
• Clot-dissolving medicines are being studied. Because clotting appears to be part of the problem, researchers are exploring combining hyaluronidase with clot-busting drugs. Early results, mostly from animals and small human studies, are interesting but not yet standard care.
• Prevention still comes first. Techniques discussed include careful knowledge of anatomy, slow low-pressure injection, very small amounts per injection, and in some areas the use of a blunt cannula or ultrasound to map vessels.

How strong is this evidence?

This is a narrative review: one expert summarizing many studies rather than a new experiment. Much of the underlying evidence comes from animals, whose blood vessels and responses differ from ours, and from small human case series. The proposed mechanisms are plausible and fit together well, but some remain theories that still need confirming in people, and newer treatments are still experimental.

What it means for you

Understanding the science should not make filler seem more frightening. Serious vascular events remain rare. What the review does show is why prevention, training and fast response matter. If you have filler, know the warning signs and report them immediately:

• Pain that is severe or out of proportion, during or after injection
• Skin that turns pale, white, dusky, blue or blotchy
• Coolness of the skin in the treated area
• Any change in vision, eye pain or a drooping eyelid

Changes in vision are a medical emergency. Call the clinic immediately and, if you cannot reach them right away, go to the nearest emergency department.

It is also worth remembering that the research described here is part of why practice has changed over the years. Emergency kits, written response plans and training in early recognition all grew out of a better understanding of how these events unfold. Asking a clinic about its plan is a reasonable and welcome question.

Questions to ask at your consultation

• Which areas of my face carry more risk, and how do you approach them?
• Is hyaluronidase kept on site, and who is trained to use it?
• What should I do if I notice a warning sign after I get home?

Frequently asked questions

Can a blockage happen days after filler?

Most occur during or shortly after injection, but signs may become clearer over the following hours. Any of the warning signs above should be reported promptly, whenever they appear.

Does pulling back on the syringe prevent this?

Research suggests it is not a reliable safety check. Careful technique, small amounts and anatomy knowledge are considered more important.

Why are some areas higher risk than others?

Some parts of the face, such as around the nose and between the brows, have vessels that connect to the eye's blood supply or have fewer backup routes for blood flow. Injectors take extra care in these areas.

If you would like to understand how filler safety and emergency planning are handled before deciding on treatment, HealthPark Medical Aesthetics welcomes those questions at a consultation.

Source

Soares DJ. Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)—Implications for Therapeutic Interventions. Molecules, 2022;27:5398. Read the study